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Adenoma pleomorfo della parete nasale laterale: caso clinico
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Summary
Pleomorphic adenoma is the most common tumour of the salivary glands. However, it is extremely rare for these to originate in 
the nose and even when they do so, it is most commonly in the nasal septum. It is important to be aware of the paucity of present-
ing symptoms (nasal obstruction and epistaxis), as the lesion may not be recognized immediately. Growth is generally restricted 
locally and the tumour is not known to spread to the neighbouring structures. Surgical resection is the treatment of choice. re-
currences and evolution to malignancy are not frequent, but long-term follow-up is recommended. The case is presented of pleo-
morphic adenoma arising from the lateral wall of the right nasal cavity, in a 34-year-old male, which was resected completely, 
endoscopically. Histological and immunohistochemical evaluation revealed the presence of a pleomorphic adenoma.
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rIaSSuNTO
L’adenoma pleomorfo è il tumore benigno più comune delle ghiandole salivari. Comunque, la sua localizzazione nasale è mol-
to rara e più comunemente origina dal setto. Importante è considerare che i sintomi di presentazione sono molto scarsi (ostru-
zione nasale e epistassi), per cui la lesione può decorrere a lungo misconosciuta. La crescita è generalmente locale e non sono 
noti casi di diffusione nelle strutture adiacenti. La resezione chirurgica è il trattamento di scelta. La recidiva e l’evoluzione 
maligna non sono frequenti, ma un lungo follow-up è da raccomandare. Presentiamo un caso di adenoma pleomorfo ad origine 
dalla parete laterale della fossa nasale di destra in un paziente di 34 anni, trattato chirurgicamente con resezione endoscopica 
completa. La valutazione istologica ed immunoistochimica hanno dimostrato la presenza di un adenoma pleomorfo.
ParOlE CHIavE: Naso • Tumori nasali • Adenoma pleomorfo • Diagnosi • Anatomia patologica
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Introduction
mixed tumour of the salivary gland or the pleomorphic 
adenoma is a benign tumour, arising mainly in the major 
salivary glands (65%), especially in the parotid and, less 
frequently, in accessory salivary glands (35%) 1. rare cases 
have been reported in the lip 2, the hard and soft palate 3, 
the lacrimal gland 4, and the external auditory canal 5. It is 
extremely rare to find these in the respiratory tract 6-8. The 
incidence is even lower in the upper respiratory tract, such 
as the nasal cavity, maxillary sinus and nasopharynx 8 9. The 
largest reported case series of intra-nasal pleomorphic ad-
enomas are those of Spiros et al. 10 with 40 cases, Compag-
no and Wong 11 with 40 cases and, more recently, Suzuki 
et al. 4 with 41 cases.
Intranasal pleomorphic adenomas generally arise in the 
nasal septal mucosa (reported incidence varies between 
82.5% 11 and 90% 12), even though the seromucosal glands 
are mainly located within the lateral nasal wall, in particular 
in the turbinates 13 14.
various theories have been proposed to explain this obser-
vation. according to Stevenson 15, remnants of the vomero-
nasal organ, an epithelium-lined duct in the cartilaginous 
nasal septum degenerated in early foetus, could be the rea-
son for the appearance of these tumours in this particular 
region. according to Ersner and Saltzman, in 1944, the 
precursors of the septal pleomorphic adenoma are ectopic 
embryonic epithelialised cells on the nasal septum mucosa, 
found during the migration of the nasal buds 16. according 
to Evans and Cruikshank, it originates directly from the ma-
tured salivary glandular tissue 6; Dawe, in1979, proposed a 
viral aetiology from polyoma virus 17.
Case report
a 34-year-old male, non-smoker, presented at our Depart-
ment, in January 2003, reporting an isolated episode of 
epistaxis from the right nasal cavity. He also complained of 
worsening of a right nasal obstruction which had been present 
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for 10 years, frontal cephalalgia and anosmia. External clini-
cal examination showed a mass arising from the lateral wall 
of the right nasal cavity and filling the naso-facial furrow.
anterior rhinoscopy revealed a smooth, pink-grey, translu-
cent, painless mass, obstructing the nasal cavity, not bleed-
ing on touch, and a deviated nasal septum to the left. The 
rest of the ear, nose, and throat examination was normal and 
there was no evidence of cervical lymphadenopathy. Com-
puted Tomography (CT) scan revealed a soft tissue mass in 
the right nasal cavity, not involving the paranasal sinuses, 
with thinning of the nasal process of the maxilla (Fig. 1). 
Endoscopic surgery, under general anaesthesia, confirmed 
the mass (2 cm in diameter) to be arising from the lateral 
wall of the right nasal cavity and extending from the an-
terior end of the inferior turbinate to the agger nasi. We 
excised the tumour completely, including the sub-periostal 
layer and a healthy margin of mucosa.
Histopathological analysis of the tumour showed a mixed 
epithelial and myxoid stromal appearance. Epithelial struc-
tures displayed different solid, trabecular and cystic growth 
patterns (Fig. 2). Immuno-histochemical stainings for 
smooth muscle actin (Fig. 3) and S100 (Fig. 4) highlighted 
the presence of an abundant myoepithelial component. The 
histo-morphological and immunophenotypical features ob-
served were consistent with the diagnosis of pleomorphic 
adenoma. There is no endoscopic evidence of recurrence 
after 4 years’ follow-up.
Discussion
Nasal pleomorphic adenoma is seen predominantly in fe-
males 4-11 usually between the third and fifth decades of life 18. 
There is no reported correlation with occupational expo-
sure or inhaled toxic chemical compounds. It is generally 
known to be a slow-growing tumour and, therefore, clinical 
symptoms appear after a long silent period. Patients com-
monly present with gradual worsening of monolateral nasal 
obstruction and occasional epistaxis. less commonly, when 
the tumoural mass reaches a relatively large size, to that of 
the nasal cavity, external swelling of the nasal pyramid as 
well as pain may be present.
Clinically, it appears as a polypoid, unilateral, sessile, trans-
lucent, pinkish-grey mass, with smooth surface and soft 
consistency. Tumours can range in size from < 0.7 cm to 
> 7 cm.
The clinical features, such as absence of superficial ulcera-
tion, no bleeding either on touch or spontaneously and lack 
of invasion of surrounding structures suggest a benign na-
ture of the mass.
Histologically, all pleomorphic adenomas have a collagen-
ous thin capsule, with a clear-cut distinction of the tumour 
tissue from the surrounding normal connective tissue. The 
tumours consist of three main structures: tubuloductal 
structure, solid area, and myxoid area. The tubuloductal 
structure presents ducts with double cell layers: cuboi-
Fig. 4. Immunostaining for S100 protein (x 400).
Fig. 1. Axial CT scan showing soft density mass in anterior por-
tion of right nasal fossa with thinness of nasal process of maxillary 
bone.
Fig. 2. Epithelial structures showing solid, trabecular and cystic 
patterns intermingled with myxoid stroma (H&E, x250).
Fig. 3. Immunostaining for smooth muscle actin (x 250).
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dal-shaped epithelial cells at the inner layer, and spindle-
shaped myoepithelial cells at the outer. Predominantly the 
solid areas consist of the spindle-shaped cells with high 
cellularity; the myxoid areas are characterised by their low 
cellularity 18.
The intra-nasal pleomorphic adenoma shows a predomi-
nance of epithelial rather than stromal elements, as com-
pared with major salivary gland tumours. The epithelial 
cells are small, oval-shaped and often arranged in cor-
dons; sometimes, they are organized in small acinous 
structures 13.
Immunohistochemical stains prove positive for various cy-
tokeratins, S100 protein, glial fibrillary acid protein (GFAP), 
vimentine, a smooth muscle actine (Sma). This describes 
the “mixed” nature of the tumour, namely, the stromal and 
the epithelial line 19.
Differential diagnosis of intra-nasal pleomorphic adeno-
ma includes both malignant and benign tumours such as 
squamous cell carcinoma (the most common intra-nasal 
malignancy), adenocarcinoma, adenoid cystic carcinoma, 
mucoepidermoid carcinoma, melanoma, olfactory esthe-
sioneuroblastoma 20, polyps, papillomas (including inverted 
papilloma), angiofibromas and osteomas.
Differential diagnosis can also be difficult in the presence of 
a “neuroestesioepithelioma” (even though the site of origin 
of such a lesion, i.e., the ethmoid plate, should suggest its 
nature, since the lateral nasal wall is extremely rare), as, in 
the early stage, it presents a small cell proliferation organ-
ized like a “rosette”, positive for S100 protein. Diagnosis 
is possible on account of the lack of an extracellular neu-
rofibrillar structure, neurotubules, neurosecretive granules 
and due to the presence of mucinous material and the rar-
ity of malpighian lobules disseminated on the pleomorphic 
adenoma 21.
regardless of where the lesion originates, the main treat-
ment modality should be surgical. While complete excision 
of the tumour with histologically clear margins is mandato-
ry, the surgical approach will depend upon the size, location 
and extension. a radical and wide resection lowers the risk 
of recurrence, especially when the capsule is interrupted 
and a direct contact with the surrounding normal tissue is 
present. approaches include lateral rhinotomy 22-24, trans-
nasal or mid-facial degloving 13-18 and intra-nasal excision. 
The present patient underwent endoscopic resection since 
the tumour was small enough to observe under the endo-
scope. The advantages of endoscopic resection include no 
external scar, less blood loss. In the presence of large mass-
es, the mid-facial degloving approach is preferred, since it 
has the advantage of wide exposure of the mass and direct 
approach to the nasal cavity.
recurrences are not frequent, Compagno and Wong re-
ported 3 cases of local recurrences in 40 patients (7.5%) 11, 
probably, as they thought, due to the amount of myxoid 
stroma of the tumour, which could be split into the surgical 
field.
The potential risk of malignant transformation of the pleo-
morphic adenoma is about 6% and is predominantly seen 
in the female patients 25. The risk is increased by delay in 
diagnosis.
A histopathologically confirmed case with adenoid cystic 
and squamous carcinomatous differentiation has been re-
ported 26.
There has also been a report of metastasis to the submandib-
ular lymph-node, in a recurrent septal pleomorphic adeno-
ma, 17 years after the first diagnosis. Even in this case, the 
microscopic features of both the primary and metastatic le-
sion were benign. In this regard, a iatrogenic theory has been 
proposed. This theory suggests that the metastasis occurs as 
a result of incomplete excision or inadvertent disruption of 
the tumour with consequent spread through haematogenous 
or lymphatic routes. Pulmonary, hepatic and bone metasta-
sis have also been reported 27.
long term follow-up is therefore necessary for early diag-
nosis of loco-regional recurrences by endoscopic examina-
tion followed by imaging (CT or mr) in case of clinical 
evidence of disease.
Conclusions
In the presence of a slow-growing unilateral mass of the 
nasal cavity, it is important to consider, among the various 
diagnoses, the presence of pleomorphic adenoma, even if 
it is not frequently encountered. Early diagnosis offers the 
possibility of a more complete excision with adequate care 
being taken not to disrupt the tumour in order to prevent 
local and distant spread of neoplastic cells. The endoscopic 
approach is preferred, as it allows complete control of the 
margins under direct vision and reduces the post-operative 
recovery period when compared to open surgery. long-
term follow-up, both endoscopic and radiologic, to exclude 
malignancy is mandatory, even if the tumour appears to be 
clinically benign and resected completely.
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